SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
ASTEX PHARMACEUTICALS
(NQNM:ASTX Last Sale: 8.76 )
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (ASTX : $8.76)
$518 million Market Cap at September 12, 2013
Employs 110.
Biomedics SubIndustry up .00% / Health Industry up .00% Today

4140 Dublin Boulevard Research Report Earnings Snapshot - Last 02/25/17
Suite 200 Fact Sheet
Dublin, CA 94568 Financial Statements
Phone: 925-560-0100 Peer Comparison
Annual Reports

James S. J. Manuso, Chmn./Pres./CEO, Michael Molkentin, CFO.
Acquired by OTSUKA HOLDINGS CO LTD (NQPK:OTSKY) for $886 million September 5, 2013. Holders received $8.50 cash per share. Approved drug, Dacogen, treats the blood disorder myelodysplastic syndromes. Also is developing drugs to treat leukemia, prostate, lung and ovarian cancer. Formarly SUPERGEN INC. Develops and commercializes drugs and products intended to treat life-threatening diseases, particularly cancer, blood cell disorders, and other serious conditions such as obesity. IPO at $6 March 12, 1996. Raised $21 MM, selling 3.5 MM shares, 21% of the outstanding. Lead Manager: Paulson. Acquired SPARTA PHARMACEUTICAL INC (OTCBB:SPTA) August 12, 1999 for 0.429 million shares, issuing 0.02518 SUPG per SPTA common, 0.41295 SUPG per SPTA preferred and warrants for 0.22 million shares of SUPG common, exercisable at $18.18.
Historical Charts    Technical Analysis
No Historical Data available for ASTX

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common ASTX $8.76 $ 0 $8.63 $8.82 3,241,181 $2.1401 $9.39 59,085
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $517,585

Split, Dividend and Symbol Change Information
Date Symbol Transaction Dividend Split New Symbol
20-JUL-12 SUPG Symbol Changed to ASTX

A293
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex